Nevirapine-based antiretroviral therapy impacts artesunate and dihydroartemisinin disposition in HIV-infected Nigerian adults

AIDS Research and Treatment

Volumn 2012, Issue , 2012, Pages

  Fehintola, Fatai A ^a   Scarsi, Kimberly K ^b   Ma, Qing ^c   Parikh, Sunil ^d   Morse, Gene D ^c   Taiwo, Babafemi ^b   Akinola, Ibrahim Tope ^e   Adewole, Isaac F ^a   Lindegardh, Niklas ^f   Phakderaj, Aphiradee ^f   Ojengbede, Oladosu ^a   Murphy, Robert L ^b   Akinyinka, Olusegun O ^a   Aweeka, Francesca T ^g  

^a UNIVERSITY OF IBADAN   (Nigeria)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF IBADAN   (Nigeria)

^f MAHIDOL UNIVERSITY   (Thailand)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84873831726     PISSN: 20901240     EISSN: 20901259     Source Type: Journal    
DOI: 10.1155/2012/703604     Document Type: Article

References (23)

1. World Health Organization, World Malaria Report: 2010 2010 World Health Organization. http://www.who.int/malaria/world-malaria-report-2010/ worldmalariareport2010.pdf
2. Joint United Nations Programme on HIV/AIDS (UNAIDS), Global report: UNAIDS report on the global AIDS epidemic. 2010, http://www.unaids.org/ globalreport/documents/20101123-GlobalReport-full-en.pdf
3. French N., Nakiyingi J., Lugada E., Watera C., Whitworth J. A. G., Gilks C. F., Increasing rates of malarial fever with deteriorating immune status in HIV-1-infected Ugandan adults. AIDS 2001 15 7 899 906 2-s2.0-0035805231 10.1097/00002030-200105040-00010 (Pubitemid 32424393)
4. Whitworth J., Morgan D., Quigley M., Smith A., Mayanja B., Eotu H., Omoding N., Okongo M., Malamba S., Ojwiya A., Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study. Lancet 2000 356 9235 1051 1056 2-s2.0-0034706326
5. World Health Organization, Guidelines for treatment of malaria 2006 World Health Organization
6. World Health Organization, Guidelines for treatment of malaria 2010 2nd World Health Organization
7. Federal Ministry of Health, National Malaria Control Programme: Strategic Plan 2009-2013. Abuja, Nigeria, 2008, http://nmcpnigeria.org/f/ Nigeria%20Annex%201-National%20Malaria%20Control%20Strategic%20Plan%202009-2013. pdf
8. 450s that metabolise anti-parasitic drugs and predictions of in vivo drug hepatic clearance from in vitro data. European Journal of Clinical Pharmacology 2003 59 5-6 429 442 10.1007/s00228-003-0636-9 (Pubitemid 37214951)
9. Ilett K. F., Ethell B. T., Maggs J. L., Davis T. M. E., Batty K. T., Burchell B., Binh T. Q., Thu L. T. A., Hung N. C., Pirmohamed M., Kevin Park B., Edwards G., Glucuronidation of dihydroartemisinin in vivo and by human liver microsomes and expressed UDP-glucuronosyltransferases. Drug Metabolism and Disposition 2002 30 9 1005 1012 2-s2.0-0036707622 10.1124/dmd.30.9.1005
10. Benakis A., Paris M., Loutan L., Plessas C. T., Plessas S. T., Pharmacokinetics of artemisinin and artesunate after oral administration in healthy volunteers. American Journal of Tropical Medicine and Hygiene 1997 56 1 17 23 2-s2.0-0031027605 (Pubitemid 27097953)
11. Newton P., Suputtamongkol Y., Teja-Isavadharm P., Pukrittayakamee S., Navaratnam V., Bates I., White N., Antimalarial bioavailability and disposition of artesunate in acute falciparum, malaria. Antimicrobial Agents and Chemotherapy 2000 44 4 972 977 2-s2.0-0034065696 10.1128/AAC.44.4.972-977.2000 (Pubitemid 30165278)
12. Li Q., Xie L. H., Haeberle A., Zhang J., Weina P., The evaluation of radiolabeled artesunate on tissue distribution in rats and protein binding in humans. American Journal of Tropical Medicine and Hygiene 2006 75 5 817 826 2-s2.0-38149059700 (Pubitemid 351627524)
13. Cheeseman S. H., Hattox S. E., McLaughlin M. M., Koup R. A., Andrews C., Bova C. A., Pav J. W., Roy T., Sullivan J. L., Keirns J. J., Pharmacokinetics of nevirapine: Initial single-rising-dose study in humans. Antimicrobial Agents and Chemotherapy 1993 37 2 178 182 2-s2.0-0027407285 (Pubitemid 23046550)
14. Riska P., Lamson M., Macgregor T., Sabo J., Hattox S., Pav J., Keirns J., Disposition and biotransformation of the antiretroviral drug nevirapine in humans. Drug Metabolism and Disposition 1999 27 8 895 901 2-s2.0-0032770872 (Pubitemid 29347589)
15. Lamson M., MacGregor T., Riska P., Erickson D., Maxfield P., Rowland L., Gigliotti M., Robinson P., Azzam S., Keirns J., Nevirapine induces both CYP3A4 and CYP2B6 metabolic pathways. Clinical Pharmacology and Therapeutics 1999 65 2 137 2-s2.0-0001474469
16. Hanpithakpong W., Kamanikom B., Dondorp A. M., Singhasivanon P., White N. J., Day N. P.J., Lindegardh N., niklas@tropmedres.ac A liquid chromatographic-tandem mass spectrometric method for determination of artesunate and its metabolite dihydroartemisinin in human plasma. Journal of Chromatography B 2008 876 1 61 68 10.1016/j.jchromb.2008.10.018
17. Kredo T., Tamara.kredo@mrc.ac.za Mauff K., Van Der Walt J. S., Wiesner L., Maartens G., Cohen K., Smith P., Barnes K. I., karen.barnes@uct.ac.za Interaction between artemether-lumefantrine and nevirapine-based antiretroviral therapy in HIV-1-infected patients. Antimicrobial Agents and Chemotherapy 2011 55 12 5616 5623 10.1128/AAC.05265-11
18. Ezzet F., Karbwang J., Population pharmacokinetics and therapeutic response of CGP 56697 (artemether + benflumetol) in malaria patients. British Journal of Clinical Pharmacology 1998 46 6 553 561 2-s2.0-0031753648 10.1046/j.1365-2125.1998.00830.x (Pubitemid 28522119)
19. Price R., Van Vugt M., Phaipun L., Luxemburger C., Simpson J., McGready R., Ter Kuile F., Kham A., Chongsuphajaisiddhi T. T., White N. J., Nosten F., Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives. American Journal of Tropical Medicine and Hygiene 1999 60 4 547 555 2-s2.0-0032960336 (Pubitemid 29233109)
20. Orrell C., Little F., Smith P., Folb P., Taylor W., Olliaro P., Barnes K. I., Pharmacokinetics and tolerability of artesunate and amodiaquine alone and in combination in healthy volunteers. European Journal of Clinical Pharmacology 2008 64 7 683 690 2-s2.0-44449129845 10.1007/s00228-007-0452-8
21. Teja-isavadharm P., Watt G., Eamsila C., Jongsakul K., Li Q., Keeratithakul D., Sirisopana N., Luesutthiviboon L., Brewer T. G., Kyle D. E., Comparative pharmacokinetics and effect kinetics of orally administered artesunate in healthy volunteers and patients with uncomplicated falciparum malaria. American Journal of Tropical Medicine and Hygiene 2001 65 6 717 721 2-s2.0-0035684848 (Pubitemid 34049461)
22. Dickinson L., Khoo S., Back D., Differences in the pharmacokinetics of protease inhibitors between healthy volunteers and HIV-infected persons. Current Opinion in HIV and AIDS 2008 3 3 296 305 2-s2.0-42049111191 10.1097/COH.0b013e3282f82bf1 (Pubitemid 351521014)
23. Fletcher C. V., Drug interactions should be evaluated in patients. Clinical Pharmacology and Therapeutics 2010 88 5 585 587 2-s2.0-77958512004 10.1038/clpt.2010.213